EastEnders confirms emotional blood cancer storyline for Denise Fox
EastEnders bosses have announced plans for a blood cancer storyline for Diane Parish's character Denise Fox.
EastEnders has confirmed a powerful blood cancer storyline for Denise Fox.
Diane Parish's character, who she has played on the BBC soap since May 2006, has been seen experiencing "unexplained tiredness" in recent episodes, and later this month she will be diagnosed with acute myeloid leukaemia.
The BBC said: "Later this month, viewers will see Denise Fox receive the diagnosis after undergoing tests prompted by concerns from those around her due to recent unexplained tiredness.
"The storyline, which will play out across the rest of the year, will follow Denise in the wake of her diagnosis, exploring its impact on her and her loved ones in the months that follow."
Meanwhile, the soap's producers have worked closely with Blood Cancer UK to make sure the story plays out as accurately and sensitively as possible.
Executive Producer, Ben Wadey, said: “It was vital to us that Denise’s storyline is portrayed with sensitivity and care, and we’re grateful to Blood Cancer UK for their advice in helping us tell this story accurately.
"As viewers follow Denise, we hope to shine a light on the realities and challenges of an acute myeloid leukaemia diagnosis and the impact it has on the person affected and those around them.”
Meanwhile, Blood Cancer UK CEO Helen Rowntree revealed the charity is glad to see such issues being highlighted on the show.
She commented: "It’s been a privilege advising the EastEnders team to ensure Denise’s storyline reflects the real experiences of people living with blood cancer and those who care for them.
"Blood cancers, which include leukaemia, lymphoma and myeloma, do not discriminate yet experiences and outcomes can vary significantly, including by ethnicity.
"Being Black and living with an aggressive blood cancer like acute myeloid leukaemia can bring additional challenges.
"We hope viewers gain a greater understanding of blood cancer’s impact and we’re pleased this issue is being highlighted on a powerful platform, helping make a ‘hidden’ cancer more visible.”
